Bulk drug imports from China increased from 62 per cent to 75 per cent in the past nine years and India continues to depend on Chinese shipments despite commissioning of various domestic manufacturing projects under the government’s production-linked incentive scheme, a report said. According to a report by Care Ratings, imports of bulk… Continue reading Bulk drug imports from China hit 75% in FY23 despite PLI scheme: Report